Far‐Field R Wave Oversensing in Dual Chamber Pacemakers Designed for Atrial Arrhythmia Management:
- 24 September 2004
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 27 (9) , 1221-1230
- https://doi.org/10.1111/j.1540-8159.2004.00613.x
Abstract
The aim of the study was to determine the incidence and practical implications of far‐field R wave oversensing (FFRWO) and its association with pacing site and lead tip to ring spacing (TTRS) in implantable devices designed to diagnose and treat atrial tachyarrhythmias and programmed with a fixed and short postventricular blanking period. The study included 395 patients who were implanted with a DDDRP pacemaker and prospectively followed. At implant and follow‐up visits FFRWO was assessed by analyzing lead electrical measures and atrial tachyarrhythmic episodes collected in the device diagnostics. During a median follow‐up of 12 months 11 (2.8%) of 395 patients showed a clinically significant FFRWO that induced inappropriate detection or pacemaker malfunctioning. The atrial pacing site of these 11 patients was right atrium appendage (RAA) for 3 patients, representing 1.1% of 254 RAA patients, coronary sinus ostium (CSO) for 7 patients, representing 7.4% of 94 CSO patients (P < 0.005 vs RAA), and lateral wall (LW) for 1 (2.9%) of 34 LW patients. The minimal value of the FFRWO to P wave ratio, measured at implant, associated with a clinically significant FFRWO was 0.6; therefore, a value of 0.5 was used as a cutoff to identify patients at risk of undesirable device behavior induced by FFRWO: there were 11 (9.6%) of 114 of RAA patients with short (≤ 10 mm) TTRS, 22 (18.8%) of 117 of RAA patients with long (≥ 17 mm) TTRS (P < 0.05 vs short TTRS), 21 (30.6%) of 64 of CSO patients short TTRS (P < 0.001 vs RAA patients with short TTRS) and 3 (30%) of 10 of CSO patients with long TTRS. The analysis showed that, despite the short postventricular blanking time, FFRWO inducing undesired functioning in AT500 pacemakers is infrequent (2.8% of patients). Compared to RAA, the CSO lead position was more frequently associated with FFRWO.TTRS < 10 mm was associated with lower risk of clinically significant FFRWO in RAA.Keywords
This publication has 17 references indexed in Scilit:
- Combined Efficacy of Atrial Septal Lead Placement and Atrial Pacing Algorithms for Prevention of Paroxysmal Atrial TachyarrhythmiaJournal of Cardiovascular Electrophysiology, 2003
- Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillatorJournal of the American College of Cardiology, 2002
- Implantable Devices for the Treatment of Atrial FibrillationNew England Journal of Medicine, 2002
- Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardiaAmerican Heart Journal, 2001
- Pace‐Termination and Pacing for Prevention of Atrial Tachyarrhythmias: Results from a Multicenter Study with an Implantable Device for Atrial TherapyJournal of Cardiovascular Electrophysiology, 2001
- Far‐Field R Wave Oversensing in a Dual Chamber Arrhythmia Management Device: Predisposing Factors and Practical ImplicationsPacing and Clinical Electrophysiology, 2001
- Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia DetectionCirculation, 2001
- Detection of Atrial Fibrillation and Flutter by a Dual-Chamber Implantable Cardioverter-DefibrillatorCirculation, 2000
- ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive SummaryCirculation, 1998
- Analysis of Atrial Sensed Far‐Field Ventricnlar Signals: A ReassessmentPacing and Clinical Electrophysiology, 1997